AR018335A1 - Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero - Google Patents
Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primeroInfo
- Publication number
- AR018335A1 AR018335A1 ARP990102033A ARP990102033A AR018335A1 AR 018335 A1 AR018335 A1 AR 018335A1 AR P990102033 A ARP990102033 A AR P990102033A AR P990102033 A ARP990102033 A AR P990102033A AR 018335 A1 AR018335 A1 AR 018335A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- carbapenic
- useful
- obtaining
- antibacterial agent
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000003607 modifier Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un compuesto carbapénico de formula (I) en donde R1 es un modificador hidrolizable en el organismo vivo; R2 y R3 son iguales o diferentes y cadauno es un alquilo C1-6; R es un grupo de formula (B) o de formula (C). Un agente antibacteriano que comprende dicho compuesto carbapénico comoingrediente activo. Este compuesto carbapénico es superior en absorcion por parte del tracto digestivo al ser administrado por vía oral y exhibesuficiente poder antibacteriano frente a una amplia gama de especies bacterianas. Por ende, el compuesto es sumamente util para la profilaxisy tratamiento de enfermedades infecciosas (particularmente infecciones bacterianas). Se describe, además, un compuesto carbapénico util como intermediariopara la obtencion del anterior.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10122499A JP2000344772A (ja) | 1998-05-01 | 1998-05-01 | カルバペネム誘導体、その用途およびその中間体化合物 |
JP10203730A JP2000344773A (ja) | 1998-07-17 | 1998-07-17 | カルバペネム誘導体、およびその用途並びにその中間体化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR018335A1 true AR018335A1 (es) | 2001-11-14 |
Family
ID=26459604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990102033A AR018335A1 (es) | 1998-05-01 | 1999-04-30 | Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero |
Country Status (24)
Country | Link |
---|---|
US (1) | US6410525B1 (es) |
EP (1) | EP1078927B1 (es) |
KR (1) | KR100589030B1 (es) |
CN (1) | CN1163494C (es) |
AR (1) | AR018335A1 (es) |
AT (1) | ATE337321T1 (es) |
AU (1) | AU760386B2 (es) |
BG (1) | BG105004A (es) |
BR (1) | BR9910098A (es) |
CA (1) | CA2330641A1 (es) |
CO (1) | CO5011051A1 (es) |
CZ (1) | CZ292623B6 (es) |
DE (1) | DE69932927D1 (es) |
HU (1) | HUP0101735A3 (es) |
ID (1) | ID27081A (es) |
NO (1) | NO20005480L (es) |
NZ (1) | NZ508493A (es) |
PL (1) | PL343728A1 (es) |
RU (1) | RU2222540C2 (es) |
SK (1) | SK16382000A3 (es) |
TR (1) | TR200003199T2 (es) |
TW (1) | TW528750B (es) |
WO (1) | WO1999057121A1 (es) |
YU (1) | YU66700A (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03000223A (es) * | 2000-07-19 | 2003-06-06 | Hoffmann La Roche | Derivados de pirrolidina como inhibidores de la enzima conversor de endotelina. |
WO2002094829A1 (fr) * | 2001-05-21 | 2002-11-28 | Kyoto Pharmaceutical Industries, Ltd. | Compose de carbapenem |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
WO2003040146A1 (fr) | 2001-11-05 | 2003-05-15 | Sumitomo Pharmaceuticals Co., Ltd. | Nouveaux composes carbapenem |
EP1612211A4 (en) | 2003-04-08 | 2008-07-02 | Dainippon Sumitomo Pharma Co | NEW CARBAPENEM COMPOUNDS |
US20070265242A1 (en) * | 2004-09-03 | 2007-11-15 | Makoto Sunagawa | Novel Carbapenem Compound |
US20090029964A1 (en) * | 2005-03-25 | 2009-01-29 | Makoto Sunagawa | Novel carbapenem compound |
JP2009507793A (ja) * | 2005-08-31 | 2009-02-26 | ワイス | グリシルサイクリンの9−アミノカルボニル置換誘導体 |
CN101376656A (zh) * | 2007-08-30 | 2009-03-04 | 山东轩竹医药科技有限公司 | 培南衍生物 |
EP2968274B1 (en) | 2013-03-15 | 2019-10-16 | Kala Pharmaceuticals, Inc. | Meropenem derivatives and uses thereof |
CA3114618C (en) * | 2018-10-01 | 2023-09-05 | Arixa Pharmaceuticals, Inc. | Derivatives of relebactam and uses thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1283906C (en) | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
JPS60233076A (ja) * | 1984-05-03 | 1985-11-19 | Sumitomo Chem Co Ltd | 新規なβ−ラクタム化合物およびその製造法 |
FI81576C (fi) | 1984-12-25 | 1990-11-12 | Sankyo Co | Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel. |
IE60588B1 (en) | 1986-07-30 | 1994-07-27 | Sumitomo Pharma | Carbapenem compound in crystalline form, and its production and use |
US5242914A (en) | 1988-04-01 | 1993-09-07 | Sankyo Company, Limited | 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics |
NO168304C (no) | 1988-04-01 | 1992-02-05 | Sankyo Co | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-(heterocyklyltio)karbapenemderivater |
AU644008B2 (en) | 1990-08-10 | 1993-12-02 | Sumitomo Pharmaceuticals Company, Limited | Beta-lactam compounds, and their production and use |
US5712267A (en) | 1991-06-04 | 1998-01-27 | Sankyo Company,. Limited | Carbapenem derivatives, their preparation and their use as antibiotics |
US5360798A (en) | 1991-07-04 | 1994-11-01 | Shionogi Seiyaku Kabushiki Kaisha | Aminooxypyrrolidinylthiocarbapenem compounds |
PT882728E (pt) | 1995-12-21 | 2002-11-29 | Sankyo Co | Derivados de 1-metilcarbapenem |
-
1999
- 1999-04-28 BR BR9910098-3A patent/BR9910098A/pt not_active Application Discontinuation
- 1999-04-28 US US09/674,363 patent/US6410525B1/en not_active Expired - Fee Related
- 1999-04-28 CZ CZ20003954A patent/CZ292623B6/cs not_active IP Right Cessation
- 1999-04-28 DE DE69932927T patent/DE69932927D1/de not_active Expired - Lifetime
- 1999-04-28 HU HU0101735A patent/HUP0101735A3/hu unknown
- 1999-04-28 CN CNB998080306A patent/CN1163494C/zh not_active Expired - Fee Related
- 1999-04-28 KR KR1020007012121A patent/KR100589030B1/ko not_active IP Right Cessation
- 1999-04-28 CA CA002330641A patent/CA2330641A1/en not_active Abandoned
- 1999-04-28 YU YU66700A patent/YU66700A/sh unknown
- 1999-04-28 NZ NZ508493A patent/NZ508493A/en unknown
- 1999-04-28 PL PL99343728A patent/PL343728A1/xx not_active IP Right Cessation
- 1999-04-28 RU RU2000130224/04A patent/RU2222540C2/ru not_active IP Right Cessation
- 1999-04-28 ID IDW20002432A patent/ID27081A/id unknown
- 1999-04-28 EP EP99918272A patent/EP1078927B1/en not_active Expired - Lifetime
- 1999-04-28 AT AT99918272T patent/ATE337321T1/de not_active IP Right Cessation
- 1999-04-28 TR TR2000/03199T patent/TR200003199T2/xx unknown
- 1999-04-28 WO PCT/JP1999/002301 patent/WO1999057121A1/ja active IP Right Grant
- 1999-04-28 AU AU36272/99A patent/AU760386B2/en not_active Ceased
- 1999-04-28 SK SK1638-2000A patent/SK16382000A3/sk unknown
- 1999-04-29 TW TW088106898A patent/TW528750B/zh not_active IP Right Cessation
- 1999-04-30 AR ARP990102033A patent/AR018335A1/es not_active Application Discontinuation
- 1999-04-30 CO CO99026262A patent/CO5011051A1/es unknown
-
2000
- 2000-10-31 NO NO20005480A patent/NO20005480L/no not_active Application Discontinuation
- 2000-11-29 BG BG105004A patent/BG105004A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BG105004A (en) | 2001-08-31 |
EP1078927B1 (en) | 2006-08-23 |
HUP0101735A3 (en) | 2002-02-28 |
ID27081A (id) | 2001-02-22 |
YU66700A (sh) | 2003-01-31 |
KR20010043196A (ko) | 2001-05-25 |
CO5011051A1 (es) | 2001-02-28 |
TW528750B (en) | 2003-04-21 |
RU2222540C2 (ru) | 2004-01-27 |
US6410525B1 (en) | 2002-06-25 |
WO1999057121A1 (fr) | 1999-11-11 |
ATE337321T1 (de) | 2006-09-15 |
NO20005480D0 (no) | 2000-10-31 |
KR100589030B1 (ko) | 2006-06-13 |
DE69932927D1 (de) | 2006-10-05 |
CZ20003954A3 (cs) | 2001-04-11 |
CN1307578A (zh) | 2001-08-08 |
SK16382000A3 (sk) | 2001-05-10 |
NZ508493A (en) | 2002-06-28 |
CN1163494C (zh) | 2004-08-25 |
AU3627299A (en) | 1999-11-23 |
CA2330641A1 (en) | 1999-11-11 |
CZ292623B6 (cs) | 2003-11-12 |
NO20005480L (no) | 2000-12-20 |
BR9910098A (pt) | 2000-12-26 |
TR200003199T2 (tr) | 2001-03-21 |
HUP0101735A2 (hu) | 2001-12-28 |
AU760386B2 (en) | 2003-05-15 |
PL343728A1 (en) | 2001-09-10 |
EP1078927A4 (en) | 2003-01-08 |
EP1078927A1 (en) | 2001-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR018335A1 (es) | Compuesto carbapenico, agente antibacteriano que lo comprende y compuesto carbapenico util como intermediario para la obtencion del primero | |
BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
JP2005511642A5 (es) | ||
BR0113861A (pt) | Derivados de ácidos 3-(heteroaril acetamido)-2-oxo-azetidina-1-sulfÈnicos como agentes antibacterianos | |
ATE232862T1 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
Modak et al. | Sulfadiazine silver-resistant Pseudomonas in burns: new topical agents | |
EP3492104A1 (de) | Verwendung von 10h-benzo[g]pteridin-2,4-dion-derivaten | |
PT1030852E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas | |
BG108498A (en) | New derivatives of oxazolidinones as antibacterial agents | |
DE69932939D1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
ES2087623T3 (es) | Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon. | |
CA2430967A1 (en) | Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents | |
BRPI0413413A (pt) | feniloxazolidinonas de piperidino substituìdo tendo atividade antimicrobiana com eficácia in vivo melhorada | |
HRP20030907B1 (en) | Pharmaceutical composition based on macrolides for topical application in ophthalmology | |
DE60030300D1 (de) | Topische behandlung zur vorbeugung von augeninfektionen | |
BR0209970A (pt) | Composto de carbapenem | |
CA2022848A1 (en) | Process for disinfecting musculoskeletal tissue and tissues prepared thereby | |
Bezhuk et al. | Effectiveness of using domestic quaternary ammonium antiseptic in general medicine and dentistry (modern view and clinical case) | |
PT1059845E (pt) | Composicao fungicida compreendendo uma benzoilfenilureia | |
JPH10265391A (ja) | 外傷用組成物 | |
WO1995033463A2 (en) | Synergistic antibiotic compositions containing a perphyrin and an antibiotic | |
AR005730A1 (es) | Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato. | |
JP2002284604A (ja) | 抗菌防黴助剤 | |
RU2008128350A (ru) | Производные дифенилмочевины | |
Still et al. | Trichosporon beigelii septicaemia in a burn patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |